Ulisse Biomed S.p.A. (BIT: UBM)
Italy
· Delayed Price · Currency is EUR 0.950
+0.044 (4.86%)
Jan 17, 2025, 5:35 PM CET
Ulisse Biomed Market Cap
Ulisse Biomed has a market cap or net worth of €21.13 million as of January 17, 2025. Its market cap has decreased by -45.73% in one year.
Market Cap
21.13M
Enterprise Value
20.34M
Revenue
420.92K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.95
Market Cap Chart
Since August 6, 2021, Ulisse Biomed's market cap has decreased from 23.35M to 21.13M, a decrease of -9.52%. That is a compound annual growth rate of -2.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 21.13M | 25.66% |
| Dec 30, 2024 | 16.81M | -52.90% |
| Dec 29, 2023 | 35.70M | 334.87% |
| Dec 30, 2022 | 8.21M | -65.95% |
| Dec 30, 2021 | 24.11M | 3.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 11.23B |
| Amplifon | 5.89B |
| DiaSorin | 5.43B |
| EL.En. | 896.48M |
| Philogen | 751.40M |
| Pharmanutra | 502.49M |
| Safilo Group | 396.43M |
| GPI S.p.A. | 300.21M |